Severe COVID-19 is a T cell immune dysregulatory disorder triggered by SARS-CoV-2-Reference-Cited by-同舟云学术

Severe COVID-19 is a T cell immune dysregulatory disorder triggered by SARS-CoV-2

Published:2022-05-26 Issue:6 Volume:18 Page:557-565
ISSN:1744-666X
Container-title:Expert Review of Clinical Immunology
language:en
Short-container-title:Expert Review of Clinical Immunology

Author:

Ameratunga Rohan¹²³^ORCID,Woon See-Tarn²³,Steele Richard²⁴,Lehnert Klaus⁵⁶,Leung Euphemia⁶⁷^ORCID,Brooks Anna E. S.⁵⁶

Affiliation:

1. Department of Clinical Immunology, Auckland Hospital, Grafton Auckland, New Zealand

2. Department of Virology and Immunology, Auckland Hospital, Grafton Auckland, New Zealand

3. Department of Molecular Medicine and Pathology, School of Medicine, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand

4. Department of Respiratory Medicine, Wellington Hospital, Wellington, New Zealand

5. School of Biological Sciences, University of Auckland, Auckland, New Zealand

6. Maurice Wilkins Centre, School of Biological Sciences, University of Auckland, Symonds St, Auckland, New Zealand Wilkins Centre, University of Auckland, Auckland, New Zealand

7. Auckland Cancer Society Research Centre, School of Medicine, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand

Publisher

Informa UK Limited

Subject

Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/1744666X.2022.2074403

Reference113 articles.

1. COVID-19: animals, veterinary and zoonotic links

2. The genetic structure of SARS‐CoV‐2 does not rule out a laboratory origin

3. The origins of SARS-CoV-2: A critical review

4. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

5. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Characteristics and outcomes of COVID‐19 in Chinese immune thrombocytopenia patients: A prospective cohort study;British Journal of Haematology;2023-11-15

2. Effect of SARS-CoV2 infection on disease flares in patients with systemic lupus erythematosus: a case–control study;Rheumatology;2023-11-08

3. Will SARS-CoV-2 impact the incidence and nature of other respiratory infections?;Expert Review of Clinical Immunology;2023-09-28

4. Selective IgA Deficiency May Be an Underrecognized Risk Factor for Severe COVID-19;The Journal of Allergy and Clinical Immunology: In Practice;2023-01

5. Is SARS-CoV-2 the only cause of long-COVID?;Aids Reviews;2022-12-29